Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, announced today that Brian Markison, Chief Executive Officer, James “JD” Schaub, Chief Operating Officer, and other key speakers, will host a call to discuss recent UPNEEQ® trends, pending expansion into the medical Aesthetics market and other general business updates as follows:
Date: Wednesday, January 19, 2022
Time: 8:30 a.m. ET
Webcast: https://experience.v-unite.com/#/aestheticrecorddemo/rvlinvestorday/room/welcome

The webcast will be available thereafter via the Company’s website at www.rvlpharma.com under the “Investor & News” section.

About Osmotica Pharmaceuticals plcOsmotica Pharmaceuticals plc (Nasdaq: OSMT) is a specialty pharmaceutical company focused on the development and commercialization of products that target markets with underserved patient populations. RVL Pharmaceuticals, Inc., is the Company’s ophthalmic and medical aesthetics subsidiary supporting UPNEEQ®.

Investor and Media Relations for Osmotica Pharmaceuticals plcLisa M. WilsonIn-Site Communications, Inc.T: 212-452-2793E: lwilson@insitecony.com

Grafico Azioni Osmotica Pharmaceuticals (NASDAQ:OSMT)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di Osmotica Pharmaceuticals
Grafico Azioni Osmotica Pharmaceuticals (NASDAQ:OSMT)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di Osmotica Pharmaceuticals